Your browser doesn't support javascript.
loading
Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.
Aoun, Mike; Coelho, Ana; Krämer, Alexander; Saxena, Amit; Sabatier, Pierre; Beusch, Christian Michel; Lönnblom, Erik; Geng, Manman; Do, Nhu-Nguyen; Xu, Zhongwei; Zhang, Jingdian; He, Yibo; Romero Castillo, Laura; Abolhassani, Hassan; Xu, Bingze; Viljanen, Johan; Rorbach, Joanna; Fernandez Lahore, Gonzalo; Gjertsson, Inger; Kastbom, Alf; Sjöwall, Christopher; Kihlberg, Jan; Zubarev, Roman A; Burkhardt, Harald; Holmdahl, Rikard.
Affiliation
  • Aoun M; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Coelho A; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Krämer A; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Saxena A; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Sabatier P; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Beusch CM; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Lönnblom E; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Geng M; Precision Medicine Institute, The Second Affiliated Hospital of Xi'an Jiaotong University , Xi'an, China.
  • Do NN; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Xu Z; Fraunhofer Institute for Translational Medicine and Pharmacology, and Fraunhofer Cluster of Excellence for Immune-Mediated Diseases , Frankfurt am Main, Germany.
  • Zhang J; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • He Y; Max Planck Institute Biology of Ageing-Karolinska Institute Laboratory, Karolinska Institute, Solna, Sweden.
  • Romero Castillo L; Division of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Abolhassani H; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Xu B; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Viljanen J; Division of Clinical Immunology, Department of Biosciences and Nutrition, Karolinska Institutet, Karolinska University Hospital, Neo Building, Solna, Sweden.
  • Rorbach J; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Fernandez Lahore G; Department of Chemistry, Biomedical Center, Uppsala University, Uppsala, Sweden.
  • Gjertsson I; Max Planck Institute Biology of Ageing-Karolinska Institute Laboratory, Karolinska Institute, Solna, Sweden.
  • Kastbom A; Division of Molecular Metabolism, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Sjöwall C; Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
  • Kihlberg J; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden.
  • Zubarev RA; Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Burkhardt H; Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Holmdahl R; Department of Chemistry, Biomedical Center, Uppsala University, Uppsala, Sweden.
J Exp Med ; 220(11)2023 11 06.
Article in En | MEDLINE | ID: mdl-37695523
ABSTRACT
B cells undergo several rounds of selection to eliminate potentially pathogenic autoreactive clones, but in contrast to T cells, evidence of positive selection of autoreactive B cells remains moot. Using unique tetramers, we traced natural autoreactive B cells (C1-B) specific for a defined triple-helical epitope on collagen type-II (COL2), constituting a sizeable fraction of the physiological B cell repertoire in mice, rats, and humans. Adoptive transfer of C1-B suppressed arthritis independently of IL10, separating them from IL10-secreting regulatory B cells. Single-cell sequencing revealed an antigen processing and presentation signature, including induced expression of CD72 and CCR7 as surface markers. C1-B presented COL2 to T cells and induced the expansion of regulatory T cells in a contact-dependent manner. CD72 blockade impeded this effect suggesting a new downstream suppressor mechanism that regulates antigen-specific T cell tolerization. Thus, our results indicate that autoreactive antigen-specific naïve B cells tolerize infiltrating T cells against self-antigens to impede the development of tissue-specific autoimmune inflammation.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Autoimmune Diseases Limits: Animals / Humans Language: En Journal: J Exp Med Year: 2023 Document type: Article Affiliation country: Suecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis / Autoimmune Diseases Limits: Animals / Humans Language: En Journal: J Exp Med Year: 2023 Document type: Article Affiliation country: Suecia